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ABSTRACT
Environmental agencies have identified a growing number of environmental contaminants that have 
endocrine disrupting activity, and these can become a major public health problem. It is suggested 
that endocrine disruptors could account for the higher-than-expected increase in the prevalence of 
some non-communicable diseases, such as obesity, diabetes, thyroid diseases, and some cancers. 
Several endocrine Disrupting Chemicals (EDCs), such as pesticides, bisphenol A, phthalates, dioxins, 
and phytoestrogens, can interact with the female reproductive system and lead to endocrine disrup-
tion. Initially, it was assumed that EDCs exert their effects by binding to hormone receptors and trans-
cription factors, but it is currently known that they may also alter the expression of enzymes involved 
in the synthesis or catabolism of steroids. Biomonitoring studies have identified these compounds in 
adults, children, pregnant women, and fetuses. Among the diseases of the female reproductive tract 
associated with EDCs exposure are the following: precocious puberty, polycystic ovary syndrome, 
and premature ovarian failure. The different populations of the world are exposed to a great number 
of chemicals through different routes of infection; despite the various available studies, there is still 
much doubt regarding the additive effect of a mixture of EDCs with similar mechanisms of action. Arq 
Bras Endocrinol Metab. 2014;58(2):153-61
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RESUMO
As diversas agências de controle ambiental têm identificado um crescente número de contaminantes 
ambientais que apresentam atividade de desregulador endócrino e estes poderão se tornar um dos 
maiores problemas de saúde pública. Sugere-se que os Desreguladores Endócrinos (EDCs) poderiam 
justificar o aumento na prevalência de algumas doenças não transmissíveis acima do esperado, 
como, por exemplo, obesidade, diabetes, doenças tireoidianas e alguns tipos de cânceres. Vários 
EDCs, como pesticidas, bisfenol A, ftalatos, dioxinas e fitoestrógenos, podem interagir com o siste-
ma reprodutivo feminino e levar à desregulação endócrina. Inicialmente, supunha-se que os EDCs 
exercessem seus efeitos através da ligação com receptores hormonais e fatores de transcrição, mas, 
atualmente, sabe-se que também podem alterar a expressão de enzimas envolvidas na síntese ou 
no catabolismo dos esteroides. Estudos de biomonitoramento têm identificado esses compostos em 
adultos, crianças, gestantes e em fetos. Entre as patologias do trato reprodutor feminino associadas 
à exposição aos EDCs, destacam-se: puberdade precoce, síndrome dos ovários policísticos e falência 
ovariana prematura. As diversas populações estão expostas a um grande número de substâncias 
químicas, através de diferentes vias de contaminação. Apesar dos diferentes estudos disponíveis, 
ainda permanece uma grande dúvida sobre o efeito aditivo de uma mistura de EDCs com similar 
mecanismo de ação. Arq Bras Endocrinol Metab. 2014;58(2):153-61
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INTRODUCTION
I n an era focused on sustainability, environment preservation is an international concern, since large 
amounts of chemicals have been released to the envi-
ronment, especially after the expansion of the industrial 
revolution. These chemicals are known as Emerging 
Organic Contaminants (EOCs), and many of them can 
alter the normal balance of endocrine systems. Because 
of this, this latter group of chemicals has been termed 
Endocrine Disrupting Chemicals (EDCs) (1).
A number of environmental agencies worldwide have 
identified a growing number of environmental contami-
nants that have endocrine disrupting activity. Currently, 
these data have been one of the greatest public health 
concerns. It has been suggested that EDCs could ex-
plain the higher-than-expected increasing prevalence of 
some diseases in growing populations, such as diabetes, 
infertility, thyroid diseases, and some cancers (2). Con-
sidering the increasing prevalence of obesity, it has been 
assumed that the presence of chemicals in the environ-
ment could predispose to its development in addition to 
the classic etiologic factors, such as increasing consump-
tion of high caloric foods, and a sedentary lifestyle. All 
this evidence can help us better understand the mecha-
nisms by which EDCs can alter hormonal control of the 
metabolism and how they contribute to the ontogeny 
of diseases, which is of great importance for the health 
of populations and for environmental management.
EDCs can originate naturally from plants or ani-
mals; however, artificial chemical compounds have cur-
rently been the main concern all over the world. EDCs 
potentially interfere with the production, secretion, 
metabolism, transport or peripheral action of endog-
enous hormones by means of their binding to hormone 
receptors (2). After binding to the receptors, the EDCs 
can trigger two types of response: mimicking hormonal 
action, which is called an agonistic effect, or leading to 
a lack of response and preventing the binding of the 
natural hormone, which is called antagonistic effect. 
Initially, it was thought that EDCs worked only by 
binding to  hormone receptors; however, currently it 
is known that EDCs may act by recruiting of coacti-
vators or correpressors in enzymatic pathways, altering 
hormone synthesis, metabolism pathways, modifying 
plasmatic clearance, or acting directly on gene expres-
sion by means of epigenetic modifications without 
changing the nucleotide sequences (1,3). The main ex-
ample of epigenetic modification is the methylation of 
cytosine residues in the promoter regulatory regions, 
which means the takeover of a methyl group at the 5th 
carbon of a cytosine followed by a guanine chain, and 
resulting in aberrant gene silencing. This is the caus-
ative mechanism of many diseases, such as tumor de-
velopment (3). A classic example of epigenetic effect 
secondary to EDCs was demonstrated after exposure 
of pregnant women to diethylstilbestrol (DES), used 
to prevent miscarriages. It was observed that female fe-
tuses exposed in the first trimester of pregnancy had a 
higher incidence of infertility in adult life, and higher 
incidence of vaginal clear cell carcinoma. The highest 
incidence of reproductive disorders was observed in the 
second generation of these women exposed to DES in 
utero, suggesting that epigenetic changes can be trans-
mitted to subsequent generations (4).
Based on the data above, the United State Environ-
mental Protection Agency (EPA) proposed a broader 
definition for endocrine disruptors, which also consi-
ders the wide diversity of mechanisms involved in endo-
crine dysfunctions. The agency describes an endocrine 
disrupting chemical as an exogenous substance, or mix-
ture that alters one or more functions of the endocrine 
system, as well as its structure, causing adverse effects 
on both the exposed organism and its offspring (1).
For many years, toxicologists believed that the EDCs 
toxic effects were directly proportional to the ingested 
dose (monotonic curve); however, several studies refute 
this concept. It has been suggested that, similar to the 
hormones, EDCs have a biphasic, U-shaped, or invert-
ed-U dose response curve (i.e., dose-response curve is 
not monotonic). Hence, very low doses could have sig-
nificant effects on cell proliferation or development (3). 
In addition, exposure to EDCs during the develop-
mental period is an important factor. Although expo-
sure of adult populations may cause damage to health, 
exposure of fetuses and infants is even more relevant, 
since the susceptibility to the adverse effects of EDCs is 
much higher during these periods. These harmful effects 
during developmental periods may occur with exposure 
to much lower doses than those considered harmful 
to adults (3). The reasons for this increased sensitivity 
could be explained by the lack of protective mechanisms 
generally present in adults, such as mechanism of DNA 
repair, presence of efficient detoxifying enzymes, liver 
maturity enabling serum clearance of chemical com-
pounds, and the protection of the blood-brain barrier.
Consequently, the period in which the exposure to 
EDCs occurs has a crucial role in its toxicity. Fetal ex-
posure may modify the cellular and tissue development 
as part of fetal programming of diseases in adulthood; 
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for example, diseases of reproductive tract and meta-
bolic diseases. Beyond the fetal period, other periods 
of increased sensitivity to the effects of EDCs include 
childhood and adolescence (5).
MAJOR CHEMICAL COMPOUNDS WITH 
ENDOCRINE DISRUPTING ACTIVITY
A wide variety of chemical compounds with endo-
crine disruption activity has been recognized by environ-
mental agencies around the world, including pesticides, 
pollutants and substances used in plastic manufacturing 
(Table 1). EDCs can be classified according to their 
use, (e.g., pesticides), or to its structural property, (e.g., 
dioxins, steroids, and polyaromatic hydrocarbons). All 
of them are widely found in the environment and may 
even be transported over long distances. In addition, 
a number of EDCs can be stored for several years in 
the fatty tissue of humans and animals, while others 
are quickly eliminated from the body. However, they 
can still cause serious effects, if exposure occurs during 
critical periods of development (3).
Below, some of the chemicals that have endocrine 
disrupting activity and are emphasized in the scientific 
literature will be discussed in detail.
Plastics
Due to their low cost of production, variety and dura-
bility, plastics have an important place in modern life. 
Their worldwide production exceeded 300 million tons 
in 2012 (3). Despite their importance, there are many 
controversies about the possible adverse effects of plas-
tic components on human health, or even plastic addi-
tive compounds, with particular emphasis on phthalates 
and bisphenol A.
Bisphenol A (BPA) is one of the chemical compounds 
of highest production worldwide: more than 6 billion 
pounds are produced annually (6). BPA is a monomer 
used in the production of polycarbonate plastics and ep-
oxy resin covering the inside surface of food cans. After 
polymerization, some BPA molecules remain unbound 
and can migrate and contaminate foods and drinks. BPA 
can also be used as a dental sealant, and as an additive in 
other plastics, such as PVC and halogenated derivatives, 
which are widely used as flame retardants.
Human BPA exposure is widespread; it has been 
identified in about 95% of urine samples of the Ameri-
can population. BPA has also been identified in the se-
rum of pregnant women, in the amniotic fluid and in 
umbilical cord blood at birth, indicating human expo-
sure during one of the windows of increased suscepti-
bility, the prenatal period (3,6). It is estimated that the 
use of BPA by the ingestion of foods packaged in cans 
that are coated internally with epoxy resin, is around 
6.6 mg/person/day (6).
Among the BPA endocrine disrupting effects, the 
most recognized are on thyroid hormones and its es-
trogenic and adipogenic activities; consequently, it has 
been debatable that there are possible adverse effects of 
BPA exposure on human health. Several studies find an 
association between serum and urinary BPA concen-
trations with increased prevalence of hypothyroidism, 
infertility, cardiovascular disease, and diabetes (6).












Nonylphenol X X X X
Nonylphenol ethoxylate X X
Octylphenol X X X X
Octylphenol ethoxylate X
Polyaromatic hydrocarbons
Polychlorinated biphenyls X X X X
Flame retardants X X
PAH X X
Oxygenated compounds
Phthalates X X X X
Bisphenol A X X X
Pesticides
Atrazine X X X X
Endosulfan X X X X
Lindane X X X
Hexachlorobenzene X X X
Pentachlorophenol X X X
Other
Dioxins and furans X X X
PAH: polycyclic aromatic hydrocarbons, UKEA: UK Environmental Agency, USEPA: Environmental 
Protection Agency of the United States, OSPAR: Oslo and Paris Commission, JEA: Environmental 
Agency of Japan. Adapted from Costa and cols. (49).
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Phthalates are plasticizers used as softeners, because 
they determine flexibility, suppleness, and elasticity of 
rigid polymers, such as PVC. They have been produced 
in large quantities since the 1930s, and are also found 
in most industrial paints, solvents, toys, personal and 
medical care products, such as cosmetics and blood 
transfusion bags. The main routes of human contami-
nation are food and skin absorption; exposure during 
the early stages of development can occur by transpla-
cental route and during breastfeeding (6).
Among all phthalates, the most worrisome is 
DEHP, Di (2-ethylhexylphthalate), whose annual pro-
duction exceeds 2 million tons. Studies with low doses 
of DEHP in mice identified toxicity to the reproductive 
system and increased proliferation and differentiation 
of adipocytes, which predisposes to visceral obesity (7). 
In humans, epidemiological studies suggest a correla-
tion between phthalate concentrations in cord blood 
and lower gestational age at delivery (6). 
Dioxins
Dioxins comprise a group of organochlorine com-
pounds including polychlorinated dibenzodioxins 
(PCDDs), polychlorinated dibenzofurans (PCDFs), 
and polychlorinated biphenyls (PCBs). The PCDDs 
and PCDFs are not produced commercially, but they 
are present in compound impurities from the produc-
tion of other chemicals, such as PCBs. These are used 
as insulators, flame-retardants, lubricants, and machine 
and transformer fluids. Dioxins are also formed during 
combustion processes, such as waste incineration and in 
smelting and refining of metals (8).
Another group of dioxins are polybrominated di-
phenyl ethers (PBDE), which are used primarily as 
flame-retardants. Whereas these compounds are added 
to some products, rather than chemically bound, they 
easily release material and still contaminate the environ-
ment. PBDEs also have bioaccumulation properties, 
and studies with human biological materials found that 
their concentrations have risen, especially in children, 
making it essential to carry out studies to assess the en-
docrine toxicity (6).
Dioxins are fat-soluble and easily contaminate the 
food chain by accumulating in adipose tissue. The main 
source of human exposure to dioxins and PCBs are 
foods of animal origin (9). In addition, dioxins are not 
readily metabolized and excreted and have a long half-
life, about 8 years in case of TCDD (2,3,7,8-tetrachlo-
rodibenzo-p-dioxin).
Several studies have evaluated the effects of human 
exposure to dioxins. In Vietnam War, veterans exposed 
to Agent Orange revealed increased prevalence of sev-
eral types of cancers, degenerative diseases of the cen-
tral nervous system, thyroid diseases, and disorders of 
sexual development. Exposure to dioxins leads to del-
eterious effects on reproductive functions by both anti-
estrogenic and anti-androgenic activities in animals, 
and carcinogenic activity was also demonstrated (3).
Organotins
Organotins, persistent organic pollutants, are being 
widely used in agriculture as fungicides, rodent repel-
lents, and ship hull paints; they are also used as stabili-
zers for plastics, such as PVC.
Human exposure to organotins occurs mainly by 
food sources: contaminated fish, oysters, or water. 
Contamination by chloride tributyltin (TBT) may be 
associated with effects on male and female reproductive 
tracts and, recently, its association with adipogenic ef-
fects has also been discussed (10).
Pesticides
Human exposure to pesticides is ubiquitous, and recent 
an UK study reported that there are approximately 127 
pesticides that have endocrine disrupting activity. Among 
the classes of pesticides that stand out are organophos-
phates, carbamates, and organochlorines. The latter is 
very persistent in the environment. Although dichlorodi-
phenyltrichloroethane (DDT) has been banned in most 
developed countries, human contamination is still identi-
fied in samples from adipose tissue and breast milk (10).
Atrazine is the most commonly detected pesticide 
contaminant of ground water and surface water. It is 
also an endocrine disruptor that, among other effects, 
alters reproductive tissues when animals are exposed 
during development (11).
Although EDCs may interfere with the endocrine 
system as a whole, many of the effects in humans are 
due to changes in estrogen signaling, one of the most 
conserved pathways in the evolution of the species. An-
ti-androgenic and anti-thyroid activities are well-known 
and can determine changes in the reproductive system, 
sexual differentiation and puberty, when exposure oc-
curred in early embryonic development (12).  
This paper will discuss some of the effects of EDCs 
on female reproductive development.
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Pubertal development
Over the past century, the average age of menarche has 
diminished in all the socioeconomic and ethnic groups, 
from 16 or 17 years to less than 13. Regarding telarche, 
there is even stronger evidence that its onset is also oc-
curring earlier (13). Besides the possibility of psycho-
logical disturbances, precocious puberty is associated 
with a greater prevalence of various co-morbidities, 
among of which are: insulin resistance, metabolic syn-
drome, breast and reproductive system cancers (14). 
It is widely known that nutritional factors influence 
the onset of puberty; however, in spite of the global 
epidemic of obesity, only increased body mass index 
does not justify this finding. Also, an increase in the fre-
quency of cases of central idiopathic precocious puberty 
has been observed. For these data, besides the known 
influence of genetic and nutritional factors that trigger 
puberty, environmental effects are also discussed. From 
this discussion, the influence of EDCs is a noteworthy 
finding. These compounds act by binding to the estro-
gen receptor or by post-receptor signaling. Additionally, 
EDCs may also act in the brain by stimulating hypotha-
lamic neurons, thereby releasing kisspeptin and promot-
ing the maturation of the hypothalamus, causing earlier 
onset of puberty, or even precocious puberty (15). 
The consumption of soy milk formulas, due to the 
presence of phytoestrogens, has been associated with pre-
cocious telarche (13). Some EDCs, such as DES, poly-
brominated biphenyls, DDT, DDE, and phthalates have 
also been associated with increased prevalence of preco-
cious puberty in humans. Interestingly, exposure during 
the prenatal period may change developmental program-
ming, and be associated with pubertal development af-
terwards without the need of a second exposure (16).
Reproductive tract
The differentiation of germ cells in the ovaries begins 
in the first trimester of intrauterine life; later, between 
the second and third quarter, they form primordial fol-
licles, and afterwards, the follicles enter a latency period 
that can last from 15 to 50 years old in women. The 
oocytes are non-degenerate cells with a longer life in 
the human body, and consequently they are exposed to 
the effects of the environment during the entire period 
of their existence.
The correct formation of ovarian follicles in the fetus 
depends on a balance between systemic concentrations 
of estrogen, inhibin and activin. Therefore, estrogen 
exposure during the critical period of formation of folli-
cles can change follicular dynamics. A classic example of 
the effects of EDCs on the ovaries is the identification 
of multioocyte follicles (MOF) in alligators inhabiting 
a lake in California; these animals were exposed during 
the early phases of the development to estrogenic com-
pounds (17). This finding shows that maintenance of 
homeostasis of local and systemic hormones during fol-
licle formation is required for normal development and 
subsequent maintenance of the quality of the oocyte. 
However, the mechanism by which endocrine disrup-
tors alter folliculogenesis and have an impact on ovarian 
function in adult women remains unknown.
Assuming the hypothesis that EDCs contribute to 
the development of ovarian disease and thus reduce 
conception rates, two questions must be considered: 
what are the ovarian structures that would be target of 
EDCs? How do these changes are manifested? The re-
productive disorders that may be related to these issues 
are: aneuploidy, polycystic ovary syndrome, primary 
ovarian failure, and changes in the menstrual cycle and 
in fecundability.
Aneuploidy
Several years ago, it was observed that mice that lived 
in damaged cages made of plastic with polycarbonates 
had a high incidence of meiotic changes in oocytes, and 
this observation led to the investigation of the estro-
genic effects of the plasticizer bisphenol A (BPA) on 
oocytes (18). The authors concluded that BPA came 
from the water consumed by the animals. When they 
were maintained in intact cages and received water with 
BPA, similar changes in oocytes were also found, and 
some of these meiotic changes have resulted in aneu-
ploidies (Table 2).
Table 2. Ovarian changes related to exposure to Endocrine Disrupting 
Chemicals
Endocrine disruptors Ovarian changes
BPA Aneuploidy
Androgens, BPA, overnutrition, PCOS
BPA, parabens, POF
Pesticides, BPA, genistein, dioxins, 
furans, biphenols
Menstrual irregularity and changes in 
fecundability
BPA: bisphenol A; PCOS: polycystic ovary syndrome; POF: primary ovarian failure.
Experimental studies of different researchers con-
clude that BPA exposure has a deleterious impact on 
oocyte maturation, and BPA and other EDCs may 
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cause similar meiotic changes in adult animals. How-
ever, changes also occur with exposure to significantly 
higher doses of BPA, during the fetal period of oogen-
esis. It is suggested that these effects may be due to the 
interference of BPA on estrogen receptor β (ERb) (19). 
Primary ovarian failure
Primary ovarian failure (POF) occurs in about 1% of 
the female population under 40 years of age, leading to 
reproductive disorders, early symptoms of menopause 
and other comorbidities (20). There are three possible 
mechanisms involved in the development of POF, in-
cluding acceleration of apoptosis, blockage of follicle 
maturation and premature activation of the follicle. 
Several causes have been studied and may have some 
association with EDCs: (a) chromosomal abnormalities 
or genetic mutations, mainly involving the X chromo-
some, such as the premutation in FMR1, (b) metabolic 
disorders such as galactosemia and 17-hydroxylase de-
ficiency, (c) virus infection, such as HIV, (d) iatrogenic 
causes: radiotherapy or chemotherapy, (e) autoimmune 
causes, (f) other factors: smoking, toxins, and other en-
vironmental factors. The cause of most cases of POF 
is not identified, and it is believed to be multifactorial 
(21).
Many EDCs lead to multioocyte follicles (MOF), a 
potential precursor of premature ovarian failure, with 
the process being mediated by ERb agonist actions 
(22). After the administration of BPA to pregnant mice 
at doses of 0.1-1,000 μg/kg between the 9th and 16th 
day of pregnancy, the appearance of ovarian cysts was 
observed in adulthood, which were significantly more 
numerous in the group that received 1 μg/kg BPA. 
Moreover, cystic adenomas were observed in the groups 
receiving higher doses, but not in the controls; these 
data support the hypothesis that BPA causes adverse 
effects on the reproductive system, if exposure occurs 
during critical periods of differentiation (23). The do-
ses used in this study are relevant for human exposure, 
since the estimated daily dose intake of BPA in the in-
fant’s formula is around 1 to 13 mg/kg. The increased 
expression of genes involved in ovarian meiosis can ex-
plain the effects of BPA on female germ cells (24). 
Another example of EDC that can affect folliculo-
genesis are parabens, which stimulate mRNA expres-
sion of anti-Mullerian hormone, and thus may inhibit 
the early stage of folliculogenesis in ovaries of newborn 
rats. In addition, parabens may regulate steroidogenesis 
by inhibiting follicular Foxl2, the main transcriptional 
repressor (25).
The compound 4-vinylcyclohexene diepoxide 
(VCD) is considered an occupational chemical ovo-
toxic (26). Repeated doses of VCD may accelerate 
the apoptotic process of atresia and selectively destroy 
primordial and primary follicles in rats and mice (27). 
Therefore, women exposed to VCD are considered at 
risk of POF.
Methoxychlor (MXC) is an organochlorine pesti-
cide used as a substitute for DDT. MXC is an estro-
genic compound that was demonstrated to have lower 
binding affinity for the estrogen receptor (28). The 
major MXC metabolites, HPTE [2, 2-bis-(p-hydroxy-
phenyl)-1, 1, 1- trichloroethane] and mono-OH MXC, 
have  estrogenic, anti-estrogenic, or anti-androgenic ac-
tions (29). Studies have demonstrated that adult mice 
and rats that were exposed to MXC showed inhibition 
of growth and implantation of embryo and ovarian at-
rophy due to inhibition of folliculogenesis, leading to 
reduced atretic follicles and ovulation (30). 
Diethylstilbestrol is a synthetic non-steroidal estro-
gen that was prescribed to pregnant women at doses of 
5-150 mg/day to prevent abortions between the years 
1940-1970. Many reproductive abnormalities, both 
cardiovascular and immunological, were reported in 
male and female offspring of women treated with DES, 
and were validated in animal models (31). Recent stud-
ies have shown that neonatal exposure to 3 μg/kg DES 
induces MOF (22).
Menstrual irregularity and fecundability 
Interference in the hormonal regulation of the men-
strual cycle results in irregular or long cycles that will 
reduce fecundity (ability to conceive in a menstrual 
cycle). Studies in humans suggest that fetal and neona-
tal exposure to EDCs can change menstrual cycles due 
to hormonal interference (32). Exposure to organo-
chlorine pesticides may make menstrual cycles shorter 
(33). Moreover, women who are exposed to non-or-
ganochlorine pesticides have 60 to 100% higher risk of 
developing long cycles or absence of menstrual cycles 
(34). Animal studies support the findings in humans; 
in utero exposure to estrogenic compounds, such as 
BPA or phytoestrogens, increases the duration of the 
estrous cycle in adult mice, and perinatal exposure to 
BPA causes irregular cycles and early suspension of cy-
clic activity (35). These changes are likely to occur due 
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to a change in hypothalamic control of LH secretion 
and ovulation (36).
A recent Brazilian study quantified organochlorine 
compounds in infertile women and compared them to 
a control group of fertile women. Exposure to organo-
chlorine compounds was most prevalent in infertile 
women, confirming the data from literature, indicating 
that dichlorodiphenyl dichloroethylene (pp’DDE) may 
negatively affect female fertility (37).
Polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) is a prevalent endo-
crine disorder in women and, in its classical presenta-
tion, is characterized by chronic anovulation and hyper-
androgenism. More recently, some milder phenotypes 
have been recognized, in which either anovulation or 
hyperandrogenism may be absent. Frequently, these 
women present a characteristic polycystic ovarian ap-
pearance at ultrasound and high prevalence of obesity, 
insulin resistance, and metabolic comorbidities, mainly 
in its classical phenotype. 
 While the pathogenesis of PCOS is still not well 
established, evidence suggests that both genetic and 
environmental factors may contribute to the clinical de-
velopment of the disease. Among these, BPA, an endo-
crine disruptor with well-known estrogen-like actions, 
has been implicated in its development (38).
 In fact, studies in animal models have shown that 
BPA acts in different ways to disturb reproductive func-
tions, including both estrogen and androgen pathways. 
BPA in vitro increases testosterone synthesis in rat 
ovarian theca-intersticial cells (39), and in male rats, 
it seems to compete with endogenous androgens for 
binding on sex hormone-binding globulin (SHBG), in-
creasing serum free androgen levels. BPA also has been 
demonstrated to decrease hepatic androgen-related hy-
droxylases, inhibiting testosterone degradation, with an 
expected increase in hormone levels (40). Moreover, 
neonatal exposure to BPA could result in PCOS de-
velopment (41). Additionally, BPA may disturb insulin 
action and glucose metabolism contributing to insulin 
resistance in intact animals (42).
In humans, studies have reported higher BPA circu-
lating levels in anovulatory women (38) and in PCOS 
patients (43), in comparison with controls. The mecha-
nisms behind this association between BPA and PCOS 
are not clear but may be, at least in part, linked to an-
drogen secretion, as suggested by data on animal stud-
ies. In this sense, BPA was found to be positively corre-
lated with androgen levels in PCOS women, suggesting 
an additive effect of BPA in an individual genetically 
susceptible to an ovarian enzymatic defect (43).
In turn, dietary products have been emerging, as 
other environmental factors associated with the devel-
opment of PCOS in susceptible individuals. Advanced 
glycated end-products (AGEs) are reactive derivatives 
of non-enzymatic glucose-protein reactions. AGEs are 
endogenously produced by aging, hyperglycemia, and 
oxidative stress, or exogenously ingested mainly from 
high-temperature processed, protein-rich foods (44). 
AGEs promote oxidative stress and insulin resistance in 
peripheral tissues by activating protein kinase C (45). 
Serum AGEs levels are increased in women with 
PCOS, and these have been positively correlated with 
serum androgen levels (46). AGEs seem to contribute 
to the elevated risk of diabetes and cardiovascular dis-
ease in the general population (45). Moreover, insulin-
resistant PCOS women have increased levels of both 
serum AGEs and their respective receptor (RAGE), 
localized in theca and granulosa cells (46), suggesting 
a putative direct action of AGEs on ovarian function.
 Interestingly, women with classic PCOS phenotype 
have higher serum AGEs levels than ovulatory PCOS 
women, indicating that AGEs are associated with the 
phenotypical severity (46). AGEs are related to the 
number of oocytes and pregnancy rates in PCOS wo-
men (47). 
It is important to underline that the environmental 
source of AGEs can be reduced by diet modifications 
that lead to a decrease on oxidative stress markers as 
well as serum testosterone levels (48). 
CONCLUSIONS
Overall, the data reviewed in this article demonstrate 
that EDCs contribute to numerous human female re-
productive disorders. The effects of EDCs depend on 
the mechanism of action, the dose, and the period of 
life in which exposure occurred. There are many re-
search gaps that limit full understanding of the real role 
of EDCs on female reproductive abnormalities. More-
over, knowledge of opportunity windows is important, 
not only for understanding the pathophysiological fac-
tors involved in the susceptibility to various diseases, 
but also for the creation of mechanisms to minimize 
the exposure of populations. There is an urgent need 
to reduce the incidence of these reproductive disorders, 
which can be addressed by studies correlating early-life 
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exposure and adult reproductive dysfunction. Finally, 
it is a matter of concern that the endocrine disrupting 
potential of the majority of chemicals in production, 
including those that are found in common consumer 
products, has not been assessed systematically in regard 
to their effects on reproduction.
Disclosure: no potential conflict of interest relevant to this article 
was reported.
REFERENCES
1. Bachega TASS, Verreschi IT, Frade EMC, D’Abronzo FH, Lazaretti-
Castro M. The environmental endocrine disruptors must receive 
the attention of Brazilian endocrinologists. Arq Bras Endocrinol 
Metab. 2011;55(2):175-6.
2. Decherf S, Demeneix BA. The obesogen hypothesis: a shift of 
focus from the periphery to the hypothalamus. J Toxicol Environ 
Health B Crit Rev. 2011;14(5-7):423-48.
3. Schug TT, Janesick A, Blumberg B, Heindel JJ. Endocrine 
disrupting chemicals and disease susceptibility. J Steroid 
Biochem Mol Biol. 2011;127(3-5):204-15.
4. Christensen BC, Marsit CJ. Epigenomics in environmental health. 
Front Genet. 2011;2:84.
5. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, 
Prins GS, Soto AM. Endocrine-disrupting chemicals: an Endocrine 
Society scientific statement. Endocr Rev. 2009;30(4):293-342.
6. Zoeller RT. Endocrine disruptors: do family lines carry an 
epigenetic record of previous generations’ exposures? 
Endocrinology. 2006;147(12):5513-4.
7. Hao C, Cheng X, Xia H, Ma X. The endocrine disruptor mono-
(2-ethylhexyl) phthalate promotes adipocyte differentiation and 
induces obesity in mice. Biosci Rep. 2012;32(6): 619-29.
8. Chang JW, Chen HL, Su HJ, Liao PC, Guo HR, Lee CC. Dioxin 
exposure and insulin resistance in Taiwanese living near a highly 
contaminated area. Epidemiology. 2010;21(1):56-61.
9. Liem AK, Fürst P, Rappe C. Exposure of populations to dioxins 
and related compounds. Food Addit Contam. 2000;17(4):241-59.
10. Casals-Casas C, Desvergne B. Endocrine disruptors: from 
endocrine to metabolic disruption. Annu Rev Physiol. 2011;73:135-
62.
11. Hayes TB, Anderson LL, Beasley VR, de Solla SR, Iguchi T, 
Ingraham H, et al. Demasculinization and feminization of male 
gonads by atrazine: consistent effects across vertebrate classes. 
J Steroid Biochem Mol Biol. 2011;127(1-2):64-73.
12. Bigsby R, Chapin RE, Daston GP, Davis BJ, Gorski J, Gray LE, et 
al. Evaluating the effects of endocrine disruptors on endocrine 
function during development. Environ Health Perspect. 
1999;107(4):613-8.
13. Fortes EM, Malerba MI, Luchini PD, Sugawara EK, Sumodjo 
L, Ribeiro Neto LM, et al. [High intake of phytoestrogens and 
precocious thelarche: case report with a possible correlation]. Arq 
Bras Endocrinol Metab. 2007;51(3):500-3.
14. Buttke DE, Sircar K, Martin C, et al. Exposures to endocrine-
disrupting chemicals and age of menarche in adolescent girls in 
NHANES (2003-2008). Environ Health Perspect. 2012;120:1613-8.
15. Patisaul HB. Effects of environmental endocrine disruptors and 
phytoestrogens on the kisspeptin system. Adv Exp Med Biol. 
2013;784:455-79.
16. Mouritsen A, Aksglaede L, Sørensen K, Mogensen SS, Leffers H, 
Main KM, et al. Hypothesis: exposure to endocrine-disrupting 
chemicals may interfere with timing of puberty. Int J Androl. 
2010;33:346-59.
17. Guillette LJ Jr, Gross TS, Masson GR, Matter JM, Percival HF, 
Woodward AR. Developmental abnormalities of the gonad and 
abnormal sex hormone concentrations in juvenile alligators 
from contaminated and control lakes in Florida. Environ Health 
Perspect. 1994;102(8):680-8.
18. Hunt PA, Koehler KE, Susiarjo M, Hodges CA, Ilagan A, Voigt RC, 
et al. Bisphenol a exposure causes meiotic aneuploidy in the 
female mouse. Curr Biol. 2003;13(7):546-53.
19. Eichenlaub-Ritter U, Vogt E, Cukurcam S, Sun F, Pacchierotti 
F, Parry J. Exposure of mouse oocytes to bisphenol A causes 
meiotic arrest but not aneuploidy. Mutat Res. 2008;651(1-2):82-92.
20. Nelson LM. Clinical practice. Primary ovarian insufficiency. N 
Engl J Med. 2009;360(6):606-14.
21. Cooper AR, Baker VL, Sterling EW, Ryan ME, Woodruff TK, Nelson 
LM. The time is now for a new approach to primary ovarian 
insufficiency. Fertil Steril. 2011;95(6):1890-7.
22. Kirigaya A, Kim H, Hayashi S, Chambon P, Watanabe H, Lguchi 
T, et al. Involvement of estrogen receptor beta in the induction 
of polyovular follicles in mouse ovaries exposed neonatally to 
diethylstilbestrol. Zoolog Sci. 2009;26(10):704-12.
23. Newbold RR, Jefferson WN, Padilla-Banks E. Prenatal exposure to 
bisphenol A at environmentally relevant doses adversely affects 
the murine female reproductive tract later in life. Environ Health 
Perspect. 2009;117(6):879-85.
24. Brieño-Enríquez MA, Reig-Viader R, Cabero L, Toran N, Martínez 
F, Roig I, et al. Gene expression is altered after bisphenol A 
exposure in human fetal oocytes in vitro. Mol Hum Reprod. 
2012;18(4):171-83.
25. Ahn HJ, An BS, Jung EM, Yang H, Choi KC, Jeung EB. Parabens 
inhibit the early phase of folliculogenesis and steroidogenesis in 
the ovaries of neonatal rats. Mol Reprod Dev. 2012;79(9):626-36.
26. Hoyer PB, Devine PJ, Hu X, Thompson KE, Sipes IG. Ovarian 
toxicity of 4-vinylcyclohexene diepoxide: a mechanistic model. 
Toxicol Pathol. 2001;29(1):91-9.
27. Kappeler CJ, Hoyer PB. 4-vinylcyclohexene diepoxide: a model 
chemical for ovotoxicity. Syst Biol Reprod Med. 2012;58(1):57-62.
28. Cummings AM. Methoxychlor as a model for environmental 
estrogens. Crit Rev Toxicol. 1997;27(4):367-79.
29. Gaido KW, Maness SC, McDonnell DP, Dehal SS, Kupfer D, 
Safe S. Interaction of methoxychlor and related compounds 
with estrogen receptor alpha and beta, and androgen receptor: 
structure-activity studies. Mol Pharmacol. 2000;58(4):852-8.
30. Martinez EM, Swartz WJ. Effects of methoxychlor on the 
reproductive system of the adult female mouse. Gross and 
histologic observations. Reprod Toxicol. 1991;5(2):139-47.
31. Newbold RR. Lessons learned from perinatal exposure to 
diethylstilbestrol. Toxicol Appl Pharmacol. 2004;199(2):142-50.
32. Chao HR, Wang SL, Lin LY, Lee WJ, Papke O. Placental transfer 
of polychlorinated dibenzo-p-dioxins, dibenzofurans, and 
biphenyls in Taiwanese mothers in relation to menstrual cycle 
characteristics. Food Chem Toxicol. 2007;45(2):259-65.
33. Axmon A, Rylander L, Strömberg U, Hagmar L. Altered menstrual 
cycles in women with a high dietary intake of persistent 
organochlorine compounds. Chemosphere. 2004;56(8):813-9.
34. Farr SL, Cooper GS, Cai J, Savitz DA, Sandler DP. Pesticide use and 
menstrual cycle characteristics among premenopausal women in 
the Agricultural Health Study. Am J Epidemiol. 2004;160(12):1194-
204.
35. Nikaido Y, Yoshizawa K, Danbara N, Tsujita-Kyutoku M, Yuri T, 
Uehara N, et al. Effects of maternal xenoestrogen exposure on 
development of the reproductive tract and mammary gland in 
female CD-1 mouse offspring. Reprod Toxicol. 2004;18(6):803-11.






















161 Arq Bras Endocrinol Metab. 2014;58/2
36. Rubin BS, Lenkowski JR, Schaeberle CM, Vandenberg LN, 
Ronsheim PM, Soto AM. Evidence of altered brain sexual 
differentiation in mice exposed perinatally to low, environmentally 
relevant levels of bisphenol A. Endocrinology. 2006;147(8):3681-91.
37. Bastos AM, de Souza Mdo C, de Almeida Filho GL, Krauss 
TM, Pavesi T, da Silva LE. Organochlorine compound levels in 
fertile and infertile women from Rio de Janeiro, Brazil. Arq Bras 
Endocrinol Metabol. 2013;57(5):346-53.
38. Takeuchi T, Tsutsumi O, Ikezuki Y, Takai Y, Taketani Y. Positive 
relationship between androgen and the endocrine disruptor, 
bisphenol A, in normal women and women with ovarian 
dysfunction. Endocr J. 2004;51:165-9.
39. Zhou W, Liu J, Liao L, Han S, Liu J. Effect of bisphenol A on 
steroid hormone production in rat ovarian theca-interstitial and 
granulosa cells. Mol Cell Endocrinol. 2008;283:12-8.
40. Hanioka N, Jinno H, Nishimura T, Ando M. Suppression of male-
specific cytochrome P450 isoforms by bisphenol A in rat liver. 
Arch Toxicol. 1998;72:387-94.
41. Fernández M, Bourguignon N, Lux-Lantos V, Libertun C. Neonatal 
exposure to bisphenol A and reproductive and endocrine 
alterations resembling the polycystic ovarian syndrome in adult 
rats. Environ Health Perspect. 2010;118:1217-22.
42. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. 
The estrogenic effect of bisphenol A disrupts pancreatic beta-cell 
function in vivo and induces insulin resistance. Environ Health 
Perspect. 2006;114:106-12.
43. Kandaraki E, Chatzigeorgiou A, Livadas S, Palioura E, Economou 
F, Koutsilieris M, et al. Endocrine disruptors and polycystic ovary 
syndrome (PCOS): elevated serum levels of bisphenol A in 
women with PCOS. J Clin Endocrinol Metab. 2011;96:E480-4.
44. Pasquali R, Stener-Victorin E, Yildiz BO, Duleba AJ, Hoeger 
K, Mason H, et al. PCOS Forum: research in polycystic ovary 
syndrome today and tomorrow. Clin Endocrinol (Oxf). 
2011;74:424-33.
45. Uribarri J, Tuttle KR. Advanced glycation end products and 
nephrotoxicity of high-protein diets. Clin J Am Soc Nephrol. 
2006;1:1293-9.
46. Diamanti-Kandarakis E, Katsikis I, Piperi C, Kandaraki E, Piouka 
A, Papavassiliou AG, et al. Increased serum advanced glycation 
end-products is a distinct finding in lean women with polycystic 
ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2008;69:634-41.
47. Jinno M, Takeuchi M, Watanabe A, Teruya K, Hirohama J, 
Eguchi N, et al. Advanced glycation end-products accumulation 
compromises embryonic development and achievement of 
pregnancy by assisted reproductive technology. Hum Reprod. 
2011;26:604-10.
48. Diamanti-Kandarakis E, Piouka A, Livadas S, Piperi C, Katsikis 
I, Papavassiliou AG, et al. Anti-mullerian hormone is associated 
with advanced glycosylated end products in lean women with 
polycystic ovary syndrome. Eur J Endocrinol. 2009;160:847-53.
49. Costa EMF, et al. Desreguladores Endócrinos. In: Proendócrino. 
vol. 4. Porto Alegre: Artmed Panamericana; 2013.
Endocrine disruptors and female development
